Medicare Enrolled

Dr. Samuel Quaynor, MD

Neurology · Gainesville, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
743 SPRING ST NE, Gainesville, GA 30501
7702199000
In practice since 2015 (11 years)
NPI: 1215319710 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Quaynor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quaynor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Quaynor

Dr. Samuel Quaynor is a neurology specialist in Gainesville, GA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Quaynor performed 1,347 Medicare services across 805 unique beneficiaries.

Between the years covered by Open Payments, Dr. Quaynor received a total of $3,639 from 43 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Quaynor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 24% volume in GA $3,639 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,347
Medicare services
Top 24% in GA for neurology
805
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~122 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
826 $60 $173
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
314 $95 $380
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
67 $37 $111
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
46 $41 $1,030
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
32 $127 $458
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
23 $156 $1,454
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
21 $91 $315
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
18 $40 $609
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$3,639
Total received (2019-2022)
Avg $910/year across 4 years
Top 43% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,639 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$14
2021
$2,139
2020
$1,291
2019
$195

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$14
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2019-2022) ›
AbbVie Inc.
$630
Novartis Pharmaceuticals Corporation
$430
Allergan, Inc.
$340
Lilly USA, LLC
$284
Biohaven Pharmaceuticals, Inc.
$175
Biogen, Inc.
$164
Teva Pharmaceuticals USA, Inc.
$156
Amgen Inc.
$129
Currax Pharmaceuticals LLC
$77
EMD Serono, Inc.
$73
Horizon Therapeutics plc
$66
Greenwich Biosciences, Inc.
$64
SK Life Science, Inc.
$63
Aprecia Pharmaceuticals, LLC
$59
Genentech USA, Inc.
$58
Adamas Pharmaceuticals, Inc.
$57
ACADIA Pharmaceuticals Inc
$56
E.R. Squibb & Sons, L.L.C.
$54
Janssen Pharmaceuticals, Inc
$52
Sunovion Pharmaceuticals Inc.
$48
Eisai Inc.
$47
Celgene Corporation
$45
Alexion Pharmaceuticals, Inc.
$45
Upsher-Smith Laboratories LLC
$38
Supernus Pharmaceuticals, Inc.
$38
PFIZER INC.
$36
US WorldMeds, LLC
$35
AstraZeneca Pharmaceuticals LP
$35
LivaNova USA, Inc.
$31
Neurelis, Inc.
$30
Lundbeck LLC
$30
UCB, Inc.
$29
Amneal Pharmaceuticals LLC
$22
Acorda Therapeutics, Inc
$17
Mallinckrodt Hospital Products Inc.
$16
Corcept Therapeutics
$16
Neurocrine Biosciences, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Medtronic, Inc.
$14
Boston Scientific Corporation
$13
Assertio Therapeutics, Inc.
$12
Electronic Waveform Lab, Inc.
$12
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · APOKYN · APTIOM · AUSTEDO · Aimovig · BOTOX · BRILINTA · Briviact · CAMBIA · DUEXIS · EMGALITY · Epidiolex · FASENRA · Fycompa · GENERAL - DBS · GOCOVRI · HUMULIN · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · Korlym · MAYZENT · Mavenclad · NORTHERA · NUPLAZID · NURTEC ODT · OCREVUS · ONZETRA XSAIL · PANZYGA · Ponvory · RAYOS · REYVOW · RYTARY · Soliris · Spritam · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VNS - Sentiva · VNS Therapy · VUMERITY · VYVANSE · Xadago · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Gainesville?
Compare neurologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
44
Per 100K population
21.1
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Quaynor is a mixed practice specialist, with above-average Medicare volume (top 24% in GA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Quaynor experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Quaynor performed 826 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quaynor receive payments from pharmaceutical companies?
Yes. Dr. Quaynor received a total of $3,639 from 43 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quaynor's costs compare to other neurologists in Gainesville?
Dr. Quaynor's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quaynor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →